Epstein Secrets

from the t5-Minute Discount Determination," The Value Examiner, July/August 2004, (iii) Estate of McCord, 120 T.C. No. 13, May 2003, and (iv) Bajaj, Denis, Ferris, and Sarin, "Finn Value and Marketability Discounts," 27 J. Corp. Law 89, Fall 2001. CONFIDENTIAL 1 WTAS LLC 71 EFTA00307466 WTAS ALIP

companies). The study concluded that companies with stocks listed on national exchanges had lower discounts than companies with stocks traded OTC. • Gelman Study's. The Gelman Study reviewed the prices paid by four closed-end investment companies specializing in restricted securities from 1968 to 1970. This stu

from the t5-Minute Discount Determination," The Value Examiner, July/August 2004, (iii) Estate of McCord, 120 T.C. No. 13, May 2003, and (iv) Bajaj, Denis, Ferris, and Sarin, "Finn Value and Marketability Discounts," 27 J. Corp. Law 89, Fall 2001. CONFIDENTIAL 1 WTAS LLC 71 EFTA00307365 WTAS ALIP

companies). The study concluded that companies with stocks listed on national exchanges had lower discounts than companies with stocks traded OTC. • Gelman Study's. The Gelman Study reviewed the prices paid by four closed-end investment companies specializing in restricted securities from 1968 to 1970. This stu

from the t5-Minute Discount Determination," The Value Examiner, July/August 2004, (iii) Estate of McCord, 120 T.C. No. 13, May 2003, and (iv) Bajaj, Denis, Ferris, and Sarin, "Finn Value and Marketability Discounts," 27 J. Corp. Law 89, Fall 2001. CONFIDENTIAL 1 WTAS LLC 71 EFTA00307264 WTAS ALIP

companies). The study concluded that companies with stocks listed on national exchanges had lower discounts than companies with stocks traded OTC. • Gelman Study's. The Gelman Study reviewed the prices paid by four closed-end investment companies specializing in restricted securities from 1968 to 1970. This stu